RETNLB Antikörper

Produktnummer ABIN7235503

Produktdetails anti-RETNLB Antikörper

Target: RETNLB (Resistin Like beta (RETNLB))

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser RETNLB Antikörper ist unkonjugiert

Applikation: ELISA, Immunohistochemistry (IHC)

Produktmerkmale: Polyclonal Antibody

Aufreinigung: Affinity purification

Immunogen: Recombinant protein of human RETNLB

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: IHC 1:50-1:200

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 0.3 mg/mL

Buffer: PBS with 0.05 % sodium azide and 50 % glycerol, PH7.4

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: -20 °C

Informationen zur Lagerung: Store at -20°C. Avoid freeze / thaw cycles.

Details zu RETNLB

Target: RETNLB (Resistin Like beta (RETNLB))

Andere Bezeichnung: RETNLB (RETNLB Produkte)

Synonyme: FIZZ1 antikoerper, FIZZ2 antikoerper, HXCP2 antikoerper, RELM-beta antikoerper, RELMb antikoerper, RELMbeta antikoerper, XCP2 antikoerper, RETNLB antikoerper, 9030012B21Rik antikoerper, Fizz2 antikoerper, Relmb antikoerper, Xcp3 antikoerper, resistin like beta antikoerper, RETNLB antikoerper, Retnlb antikoerper

Hintergrund: Resistin-like betais aproteinthat in humans is encoded by theRETNLBgene. An infusion of either resistin or RELMB in rats rapidly induced severe hepatic but not peripheral insulin resistance. Increases in circulating resistin or RELMB levels markedly stimulated hepatic glucose production despite the presence of fixed physiologic insulin levels. This enhanced rate of glucose output was due to increased flux through glucose-6-phosphatase. The results supported the notion that a novel family of fat- and gut-derived circulating proteins modulates hepatic insulin action.

UniProt: Q9BQ08

Pathways: Hormone Activity